SPO Global Inc の最大収益セグメントは Bio-pharmaceutical Research and Development, Development and Sales of Medical Information Sofware, Medical High-tech Introduction, Production and Sales of Medical Quality Supplies, Dietary Supplement, Medicine and Medical Equipment Supplies で、最新の利益発表における収益は 12,436,288 です。地域別に見ると、United States が SPO Global Inc の主要市場であり、収益は 12,436,288 です。